When people hear the word benzomorphan, they may assume it refers to a medication, street drug, or newly emerging synthetic opioid. Benzomorphan is actually the name of a chemical framework that has been used to create several pharmacologically active compounds.
Some drugs built from the benzomorphan structure interact with opioid receptors and produce pain relief. Depending on the specific compound, they may also cause sedation, impaired judgment, unpleasant changes in perception, physical dependence, or opioid addiction.
Pentazocine is the best-known example. It was developed as an opioid pain medication with different receptor activity than morphine and other conventional opioids. However, different does not mean harmless. Official medication labeling warns that pentazocine products can cause addiction, misuse, respiratory depression, overdose, and death.
Understanding benzomorphan drugs can help patients and families recognize why an older or less familiar pain medication may still require the same caution as other prescription opioids.
Benzomorphan Is a Drug Structure, Not One Specific Medication
Benzomorphan refers to a compact chemical scaffold related to the structural features found in morphine-like drugs. The parent benzomorphan compound has the molecular formula C12H15N, but modifications to that structure can create substances with substantially different effects.
This is why two compounds associated with the same chemical family may not behave identically. Changes to a molecule can affect:
- Which receptors it binds to
- How strongly it activates those receptors
- Whether it blocks the effects of another opioid
- How much pain relief it provides
- Whether it produces euphoria or dysphoria
- Its potential for dependence and misuse
In practical terms, most patients will never be prescribed something labeled simply “benzomorphan.” They are more likely to encounter a specific benzomorphan-derived medication, particularly pentazocine.
Why Were Benzomorphan Opioids Developed?
Many opioid medications provide effective pain relief but also carry serious risks. Researchers have long attempted to develop analgesics that retain pain-relieving effects while reducing euphoria, respiratory depression, dependence, or misuse potential.
Certain benzomorphan compounds were developed as part of this effort. Instead of acting like full mu-opioid receptor agonists, some were designed to produce mixed agonist-antagonist effects.
A mixed agonist-antagonist opioid may:
- Activate one type of opioid receptor
- Weakly activate another receptor
- Block certain effects produced by other opioids
- Produce pain relief alongside unusual psychological effects
This receptor profile can alter the drug’s experience, but it does not remove its opioid-related risks.
Pentazocine and the Benzomorphan Drug Class
Pentazocine is a benzomorphan opioid analgesic described by PubChem as an opioid agonist-antagonist. It has historically been used to manage moderate to severe pain.
Pentazocine has been available alone and in combination products. One formulation combines pentazocine with naloxone. The naloxone component was included largely to discourage injection misuse rather than to eliminate the effects of orally administered pentazocine.
The tablets are intended for oral use only. DailyMed warns that injecting altered pentazocine-naloxone tablets may cause severe and potentially fatal reactions.
Pentazocine products and availability have changed over time. MedlinePlus reports that pentazocine alone has been discontinued in the United States, while information remains available for pentazocine-naloxone products.
Is Pentazocine a Strong Opioid?
Describing an opioid as strong or weak can be misleading. Potency does not fully predict whether a person will develop dependence, experience withdrawal, misuse a medication, or overdose.
DailyMed describes oral pentazocine as a Schedule IV opioid analgesic and notes that a 50-milligram oral dose has historically been considered roughly comparable in analgesic effect to 60 milligrams of codeine.
Pentazocine may have a lower federal scheduling classification than opioids such as oxycodone or fentanyl, but Schedule IV does not mean there is no addiction risk. The DEA lists Talwin, a former brand name for pentazocine, among Schedule IV controlled substances.
A person’s risk also depends on factors such as:
- Dose and frequency of use
- Length of treatment
- Personal or family history of addiction
- Taking medication differently than prescribed
- Combining it with alcohol or sedatives
- Co-occurring mental health conditions
- Access to multiple opioid medications
How Benzomorphan Opioids Affect the Brain
The body contains several opioid receptor systems. The three most commonly discussed are mu, kappa, and delta receptors.
Full mu-opioid agonists can produce significant pain relief, euphoria, sedation, constipation, slowed breathing, tolerance, and physical dependence. Benzomorphan-derived opioids may produce a more complex response because they do not always act primarily as full mu agonists.
Pentazocine is associated with agonist activity at kappa-opioid receptors and weaker antagonist or partial agonist activity at mu-opioid receptors. This mixed activity can provide analgesia while also causing effects that may feel different from those produced by morphine or oxycodone.
Possible psychological effects may include:
- Uneasiness or dysphoria
- Confusion
- Anxiety
- Disorientation
- Unusual thoughts or perceptions
- Hallucination-like experiences
Naloxone labeling notes that naloxone can reverse some of the psychotomimetic and dysphoric effects associated with agonist-antagonist opioids such as pentazocine.
Benzomorphan Opioids Compared With Traditional Opioids
| Feature | Benzomorphan Opioids Such as Pentazocine | Traditional Full-Agonist Opioids |
|---|---|---|
| Primary role | Pain relief | Pain relief |
| Receptor activity | Often mixed agonist-antagonist activity | Primarily full mu-opioid agonism |
| Examples | Pentazocine, phenazocine and certain research compounds | Morphine, oxycodone, hydrocodone and fentanyl |
| Euphoria | Possible, but may be less predictable | Commonly associated with misuse |
| Dysphoria | May be more prominent with certain compounds | Less characteristic |
| Physical dependence | Possible | Possible |
| Withdrawal | Possible with repeated use | Possible with repeated use |
| Respiratory depression | Possible and potentially life-threatening | Possible and potentially life-threatening |
| Controlled status | Depends on the specific substance | Depends on the specific substance |
| Safe without monitoring | No | No |
The distinction between these categories is pharmacological. It should not be interpreted as proof that one class is automatically safe or incapable of causing addiction.
Side Effects of Pentazocine and Related Opioids
Benzomorphan-derived medications can cause many of the same general side effects seen with other opioid drugs.
Common or clinically important effects may include:
- Drowsiness
- Dizziness
- Nausea or vomiting
- Constipation
- Sweating
- Headache
- Dry mouth
- Weakness
- Impaired coordination
- Confusion
- Changes in mood or perception
More serious reactions can include severely slowed breathing, extreme sedation, low blood pressure, loss of consciousness, and overdose.
The pentazocine-naloxone medication guide warns that the product can place patients at risk of opioid addiction, abuse, misuse, overdose, and death even when it is prescribed for a legitimate medical purpose.
Can Benzomorphan Drugs Be Addictive?
Yes. A benzomorphan-derived opioid can contribute to addiction when its use becomes compulsive and continues despite harmful consequences.
Addiction does not always begin with recreational drug use. It may develop after a person receives an opioid for an injury, surgery, or chronic pain condition. Over time, the person may begin taking larger doses, using the medication more frequently, or relying on it for emotional relief instead of pain control.
Warning signs may include:
- Running out of medication earlier than expected
- Taking doses more often than prescribed
- Using the medication for stress, sleep, or emotional discomfort
- Seeking prescriptions from multiple providers
- Concealing the amount being used
- Feeling unable to function without the medication
- Continuing use despite relationship, work, or health problems
- Experiencing intense cravings
- Trying unsuccessfully to reduce or stop
- Combining the medication with other substances to change its effects
MedlinePlus warns that pentazocine-naloxone may be habit-forming and advises patients not to increase the dose, take it more frequently, alter its route of use, or stop it suddenly without medical direction.
Physical Dependence Is Not Always the Same as Addiction
Physical dependence means the nervous system has adapted to the repeated presence of a substance. When the medication is reduced or stopped, withdrawal symptoms may occur.
Addiction involves a broader pattern of impaired control, cravings, continued use despite consequences, and compulsive substance-seeking behavior.
A person may be physically dependent on a prescribed opioid without meeting the criteria for opioid use disorder. However, dependence can still create medical risks, especially when someone attempts to stop suddenly or begins using additional substances to avoid withdrawal.
What Does Benzomorphan Opioid Withdrawal Feel Like?
Withdrawal from pentazocine or another opioid-active benzomorphan compound may resemble withdrawal from other opioids.
Possible symptoms include:
- Anxiety or restlessness
- Muscle and joint pain
- Sweating
- Chills
- Runny nose
- Watery eyes
- Yawning
- Difficulty sleeping
- Abdominal cramping
- Nausea
- Vomiting
- Diarrhea
- Rapid pulse
- Irritability
- Strong opioid cravings
The intensity and duration of withdrawal can vary based on the drug, dose, frequency of use, length of exposure, metabolism, and whether other substances are also involved.
Someone who has been taking pentazocine regularly should speak with a medical professional before stopping. A gradual taper may be recommended for patients who are physically dependent but do not require a higher level of addiction treatment.
Why Pentazocine Can Trigger Withdrawal From Other Opioids
Mixed agonist-antagonist opioids create an additional concern for people who are physically dependent on full opioid agonists.
Because pentazocine can block or displace some mu-opioid receptor activity, it may rapidly reduce the effects of another opioid. In a person who is already dependent on drugs such as heroin, morphine, oxycodone, or fentanyl, that receptor change may trigger abrupt withdrawal.
This is sometimes called precipitated withdrawal.
Symptoms can begin quickly and may feel substantially more intense than gradually developing opioid withdrawal. Patients should tell medical providers about all opioid use before receiving an agonist-antagonist pain medication.
Dangerous Benzomorphan Drug Combinations
The greatest immediate concern is combining an opioid with another substance that suppresses the central nervous system.
High-risk combinations include:
- Alcohol
- Benzodiazepines
- Sleep medications
- Barbiturates
- Other opioid pain medications
- Heroin or illicit fentanyl
- Certain muscle relaxers
- Sedating antihistamines
- Gabapentinoids when used without medical supervision
Combining central nervous system depressants can increase sedation and suppress the brain’s ability to regulate breathing. A person may become difficult to wake, breathe irregularly, lose consciousness, or die.
People should also avoid changing the form of a medication or using it through a route other than the one prescribed. Pentazocine-naloxone tablets are intended only for oral administration, and injection misuse has been associated with severe reactions.
Signs of a Pentazocine or Opioid Overdose
A pentazocine overdose may cause:
- Slow, shallow, or stopped breathing
- Extreme sleepiness
- Inability to wake
- Blue, gray, or pale lips and fingertips
- Pinpoint or abnormal pupils
- Limpness
- Weak pulse
- Low blood pressure
- Gurgling or choking sounds
- Loss of consciousness
MedlinePlus identifies pentazocine as an opioid and warns that taking more than the recommended amount can cause an overdose.
Call 911 immediately when an opioid overdose is suspected. Administer naloxone when available and continue following the dispatcher’s instructions. Naloxone nasal spray is used alongside emergency medical care to reverse life-threatening opioid overdose effects.
Do not assume that someone will recover simply because they begin breathing or wake up after naloxone. Its effects may wear off before the opioid has left the body, and additional doses may be necessary.
When Prescription Use Becomes a Larger Problem
Occasional medication misuse does not always look dramatic. The earliest changes may involve rationalizing extra doses, repeatedly requesting early refills, or using medication for reasons unrelated to physical pain.
Over time, a person may organize more of their life around obtaining, taking, and recovering from the drug.
It may be time to seek professional help when:
- The medication no longer feels optional
- Attempts to cut back repeatedly fail
- Withdrawal prevents stopping
- Opioids are being purchased outside medical care
- Multiple substances are being combined
- Work or family responsibilities are being neglected
- The person has experienced an overdose
- Mental health symptoms are worsening
- Drug use continues despite medical consequences
Early treatment can prevent the situation from progressing further.
Treatment for Benzomorphan or Prescription Opioid Addiction
Treatment should be based on the person’s full pattern of opioid use rather than the name of a single medication. Someone taking pentazocine may also be using other prescription opioids, illicit fentanyl, alcohol, benzodiazepines, or stimulants.
A clinical assessment can identify:
- Which substances are being used
- How frequently and in what amounts
- Whether physical dependence is present
- Current withdrawal and overdose risk
- Co-occurring mental health conditions
- Chronic pain or other medical needs
- Previous treatment experiences
- The safest level of care
Treatment may include medical detoxification, residential treatment, medication for opioid use disorder, behavioral therapy, relapse-prevention planning, family support, and continuing care.
Medical Detoxification
Medical detox provides monitoring and symptom management during the initial withdrawal period. It may be appropriate when a person has significant physical dependence, uses multiple substances, has previously experienced complicated withdrawal, or lacks a stable environment in which to stop.
Detox alone is not usually enough to address opioid addiction. It stabilizes the immediate physical condition so that the person can participate more effectively in continuing treatment.
Medication for Opioid Use Disorder
Depending on the clinical situation, opioid use disorder may be treated with medications such as buprenorphine, methadone, or extended-release naltrexone.
These medications are not interchangeable, and the timing of treatment matters. A physician must consider which opioids have been used, when they were last taken, and whether the person is currently in withdrawal.
Medication can be combined with counseling, recovery support, case management, and treatment for co-occurring mental health conditions.
Residential Addiction Treatment in Tennessee
Residential treatment provides a structured setting removed from the people, substances, and circumstances that may reinforce continued drug use.
At Brooks Healing Center, treatment can help individuals examine the physical, psychological, and behavioral aspects of opioid addiction. Care may address:
- Cravings and relapse patterns
- Trauma and unresolved emotional distress
- Anxiety, depression, or other co-occurring conditions
- Family and relationship concerns
- Coping skills
- Daily structure
- Accountability
- Recovery planning
- Transition into ongoing outpatient care
The goal is not simply to discontinue a specific medication. It is to help the individual build a sustainable life in which returning to opioid misuse becomes less likely.
Find Help for Opioid Addiction at Brooks Healing Center
Benzomorphan drugs may be less familiar than fentanyl, heroin, or oxycodone, but medications such as pentazocine still act on opioid systems and can cause serious harm.
A lower scheduling classification, mixed receptor profile, or history as a prescription pain medication does not rule out addiction. When someone is unable to control their opioid use, experiences withdrawal, or continues using despite consequences, professional treatment may be appropriate.
Brooks Healing Center provides residential addiction treatment in Normandy, Tennessee, for people experiencing opioid and other substance use disorders. Contact our admissions team to discuss your situation, learn about available treatment options, and determine an appropriate next step.
Frequently Asked Questions
Is benzomorphan the same as pentazocine?
No. Benzomorphan is a chemical structure or drug family. Pentazocine is a specific opioid medication derived from the benzomorphan framework.
Is benzomorphan a street drug?
The term benzomorphan does not ordinarily refer to a single street drug. It describes a chemical scaffold associated with multiple pharmaceutical and research compounds.
Is pentazocine still used?
Pentazocine has historically been used for moderate to severe pain. MedlinePlus reports that pentazocine alone has been discontinued in the United States, although pentazocine-naloxone medication information and product labeling remain available. Availability can depend on the product, manufacturer, and location.
Is pentazocine a narcotic?
Yes. Pentazocine is an opioid or narcotic analgesic. Official labeling describes pentazocine-naloxone as a strong prescription pain medicine containing an opioid.
What schedule is pentazocine?
Pentazocine is federally classified as a Schedule IV controlled substance. The DEA lists Talwin among examples of Schedule IV drugs.
Can pentazocine cause dependence?
Yes. Regular opioid exposure can cause physical dependence. Stopping suddenly may produce withdrawal symptoms, so patients should consult their prescribing professional before reducing or discontinuing the medication.
Can someone overdose on pentazocine?
Yes. Pentazocine can cause severe respiratory depression and fatal overdose, particularly when it is taken in excessive amounts or combined with alcohol, sedatives, or other opioids.
Does the naloxone in pentazocine-naloxone prevent overdose?
No. The naloxone component does not make the medication overdose-proof or prevent addiction when the tablets are taken orally. The medication guide still warns of addiction, misuse, overdose, and death.
Can pentazocine cause precipitated withdrawal?
It may trigger withdrawal in someone physically dependent on a full opioid agonist because its mixed agonist-antagonist effects can interfere with mu-opioid receptor activity.
How is pentazocine addiction treated?
Treatment may include medical detox, medication for opioid use disorder when clinically appropriate, residential or outpatient care, behavioral therapy, treatment for co-occurring conditions, and long-term relapse-prevention support.
Sources
DailyMed. (2025). Pentazocine hydrochloride and naloxone hydrochloride tablets: Prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=41ebdaaf-3bbc-419f-b996-0341efc14623
Drug Enforcement Administration. (n.d.). Drug scheduling. U.S. Department of Justice. https://www.dea.gov/drug-information/drug-scheduling
MedlinePlus. (2025, September 15). Pentazocine. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a601092.html
MedlinePlus. (2025, September 15). Pentazocine and naloxone. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a625096.html
MedlinePlus. (2025, January 8). Pentazocine overdose. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/002519.htm
MedlinePlus. (2024, July 20). Naloxone nasal spray. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a616003.html
National Center for Biotechnology Information. (n.d.). Pentazocine hydrochloride. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Pentazocine-Hydrochloride
National Center for Biotechnology Information. (n.d.). 6,7-Benzomorphan. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/52921323
National Center for Biotechnology Information. (n.d.). Cyclazocine. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Cyclazocine
National Center for Biotechnology Information. (n.d.). Phenazocine hydrobromide. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/13501022
U.S. Food and Drug Administration. (2011). Pentazocine hydrochloride and acetaminophen tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018458s016lbl.pdf
